AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34157417 — intervention group
Group type: COMPARATOR
Intervention: Control vaccine
Number of subjects: 894
Study 36220481 — intervention group
Group type: EXPERIMENTAL
Intervention: PSE-enhanced conventional care
Number of subjects: 148
Study 36220481 — intervention group
Group type: COMPARATOR
Intervention: Conventional care alone
Number of subjects: 148
Study 32720780 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (6 mg·kg‐1)
Number of subjects: 16
Study 32720780 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sucrose)
Number of subjects: 16
Study 32812666 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial circumferential epitendinous suture (180° on the palmar side)
Number of subjects: 36
Study 32812666 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete circumferential epitendinous suture (360° and double knotting technique)
Number of subjects: 36
Study 32812666 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete circumferential epitendinous suture (360° and single knotting technique)
Number of subjects: 36
Study 32812666 — intervention group
Group type: COMPARATOR
Intervention: Complete circumferential epitendinous suture (both single and double knotting techniques)
Number of subjects: 36
Study 32812666 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete circumferential epitendinous suture
Number of subjects: 36
Study 32812666 — intervention group
Group type: COMPARATOR
Intervention: Partial circumferential epitendinous suture
Number of subjects: 36
Study 33651448 — intervention group
Group type: EXPERIMENTAL
Intervention: rs671 GA/AA genotype
Number of subjects: 2500
Study 33651448 — intervention group
Group type: EXPERIMENTAL
Intervention: Poor control of high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, blood pressure, and glycated levels
Number of subjects: 2500
Study 33651448 — intervention group
Group type: EXPERIMENTAL
Intervention: Drinking alcohol
Number of subjects: 2500
Study 33651448 — intervention group
Group type: COMPARATOR
Intervention: Cox regression analysis
Number of subjects: 2500
Study 32355123 — intervention group
Group type: EXPERIMENTAL
Intervention: Besifovir dipivoxil maleate (BSV) for 144 weeks
Number of subjects: 197
Study 32355123 — intervention group
Group type: COMPARATOR
Intervention: Tenofovir disoproxil fumarate (TDF) followed by BSV for 96 weeks
Number of subjects: 197
Study 32355123 — intervention group
Group type: EXPERIMENTAL
Intervention: BSV for 144 weeks
Number of subjects: 197
Study 32355123 — intervention group
Group type: COMPARATOR
Intervention: TDF followed by BSV
Number of subjects: 197
Study 36174092 — intervention group
Group type: EXPERIMENTAL
Intervention: Care priorities for severe pediatric TBI before the COVID-19 pandemic (2019)
Number of subjects: 15
Study 36174092 — intervention group
Group type: EXPERIMENTAL
Intervention: Care priorities for severe pediatric TBI during the COVID-19 pandemic (2021)
Number of subjects: 15
Study 36174092 — intervention group
Group type: COMPARATOR
Intervention: Comparison of care priorities between 2019 and 2021
Number of subjects: 15
Study 36174092 — intervention group
Group type: COMPARATOR
Intervention: Association of hospital volume and subspecialty resource availability with prioritization of key process actions
Number of subjects: 15
Study 32561404 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal 25-hydroxyvitamin D levels in the first half of pregnancy
Number of subjects: 2134
Study 32561404 — intervention group
Group type: COMPARATOR
Intervention: Matched controls (not specified)
Number of subjects: 2134
Study 32911981 — intervention group
Group type: EXPERIMENTAL
Intervention: HBP with visualization of the tricuspid valve annulus
Number of subjects: 50
Study 32911981 — intervention group
Group type: COMPARATOR
Intervention: Standard method of HBP implantation
Number of subjects: 50
Study 34614447 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP‐4199 200 mg/d
Number of subjects: 289
Study 34614447 — intervention group
Group type: EXPERIMENTAL
Intervention: SEP‐4199 400 mg/d
Number of subjects: 289
Study 34614447 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 289
Study 34750553 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 200 mg twice daily
Number of subjects: 93
Study 34750553 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 150 mg daily
Number of subjects: 93
Study 34750553 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 50 mg daily
Number of subjects: 93
Study 34750553 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 34750553 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib (all doses)
Number of subjects: 93
Study 34750553 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenebrutinib 150 mg daily and 200 mg twice daily
Number of subjects: 93
Study 34561715 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of estradiol (E2) after observation of a gestational sac and heartbeat (study group)
Number of subjects: 291
Study 34561715 — intervention group
Group type: COMPARATOR
Intervention: Continued estradiol (E2) administration until week 12 of gestational age (control group)
Number of subjects: 291
Study 34561715 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups continued progesterone-in-oil administration until week 12 of gestational age
Number of subjects: 291
Study 34561715 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of serum levels for E2 and progesterone
Number of subjects: 291
Study 34561715 — intervention group
Group type: COMPARATOR
Intervention: Maternal complications
Number of subjects: 291
Study 33604969 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive clobetasol 0.05% cream applied twice per day for 8 weeks
Number of subjects: 116
Study 33604969 — intervention group
Group type: COMPARATOR
Intervention: Reactive clobetasol 0.05% cream applied twice per day for 8 weeks
Number of subjects: 116
Study 33604969 — intervention group
Group type: EXPERIMENTAL
Intervention: Preemptive clobetasol
Number of subjects: 116
Study 33604969 — intervention group
Group type: COMPARATOR
Intervention: Reactive clobetasol
Number of subjects: 116
Study 32182674 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body electromyostimulation (WB-EMS) during exercise
Number of subjects: 34
Study 32182674 — intervention group
Group type: COMPARATOR
Intervention: Control group (aerobic and strength training without WB-EMS)
Number of subjects: 34
Study 34289481 — intervention group
Group type: EXPERIMENTAL
Intervention: Prosody Treatment Program (1 hour, once per week for 3 months)
Number of subjects: 34
Study 34289481 — intervention group
Group type: COMPARATOR
Intervention: Conventional auditory and language training (control)
Number of subjects: 34
Study 33159697 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance Care Planning (ACP) video intervention
Number of subjects: 2538
Study 33159697 — intervention group
Group type: COMPARATOR
Intervention: Usual ACP practices (Control)
Number of subjects: 2538
Study 35240053 — intervention group
Group type: EXPERIMENTAL
Intervention: Elective ipsilateral upper-neck irradiation (UNI)
Number of subjects: 446
Study 35240053 — intervention group
Group type: COMPARATOR
Intervention: Whole-neck irradiation (WNI)
Number of subjects: 446
Study 32461626 — intervention group
Group type: EXPERIMENTAL
Intervention: Expression initiation within 181–360 minutes following delivery
Number of subjects: 180
Study 32461626 — intervention group
Group type: COMPARATOR
Intervention: Expression initiation within 60 minutes following delivery
Number of subjects: 180
Study 32461626 — intervention group
Group type: COMPARATOR
Intervention: Expression initiation within 61–180 minutes following delivery
Number of subjects: 180
Study 36201966 — intervention group
Group type: EXPERIMENTAL
Intervention: Facilitated tucking position (n=44)
Number of subjects: 89
Study 36201966 — intervention group
Group type: COMPARATOR
Intervention: Routine application (n=45)
Number of subjects: 89
Study 33373806 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 78
Study 33373806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 78
Study 32334478 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day regimen of 500 mg amoxicillin four times daily, 500 mg tetracycline four times daily, and 20 mg omeprazole twice daily
Number of subjects: 77
Study 32334478 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day regimen of 500 mg amoxicillin four times daily, 500 mg tetracycline four times daily, and 20 mg omeprazole twice daily
Number of subjects: 77
Study 32334478 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-day regimen
Number of subjects: 77
Study 35685075 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer-mediated intervention (PMI)
Number of subjects: 55
Study 35685075 — intervention group
Group type: COMPARATOR
Intervention: Behavioral therapy based on applied behavior analysis (ABA) (control group)
Number of subjects: 55
Study 33172491 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in Japan's policy on recruiting EPA nurses
Number of subjects: 432
Study 33172491 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to recruit EPA nurses
Number of subjects: 432
Study 33172491 — intervention group
Group type: EXPERIMENTAL
Intervention: Interest in the policy (predictor for recruitment intention)
Number of subjects: 432
Study 33172491 — intervention group
Group type: EXPERIMENTAL
Intervention: Perception of EPA nurses (predictor for recruitment intention)
Number of subjects: 432
Study 35064813 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagen sponge containing simvastatin
Number of subjects: 22
Study 35064813 — intervention group
Group type: COMPARATOR
Intervention: Control group (sockets retained the clot)
Number of subjects: 22
Study 34158293 — intervention group
Group type: EXPERIMENTAL
Intervention: Left bundle branch area pacing (LBBaP)
Number of subjects: 210
Study 34158293 — intervention group
Group type: COMPARATOR
Intervention: Right ventricular apex pacing (RVAP)
Number of subjects: 210
Study 35960611 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematic Suture (SS)
Number of subjects: 143
Study 35960611 — intervention group
Group type: COMPARATOR
Intervention: Conservative Management (CM)
Number of subjects: 143
Study 32621262 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) associated with Preventive Oral Care Program (POCP)
Number of subjects: 48
Study 32621262 — intervention group
Group type: COMPARATOR
Intervention: Preventive Oral Care Program (POCP) alone
Number of subjects: 48
Study 32621262 — intervention group
Group type: EXPERIMENTAL
Intervention: Photobiomodulation therapy (PBMT) associated with POCP
Number of subjects: 48
Study 32529581 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking (univariable and multivariable MR analysis)
Number of subjects: 378
Study 32529581 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Mass Index (BMI) (univariable and multivariable MR analysis)
Number of subjects: 378
Study 34315495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4)
Number of subjects: 9248
Study 34315495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4) among men
Number of subjects: 9248
Study 34315495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels > 28.72 mg/dL (Q4) among individuals age > 60 years
Number of subjects: 9248
Study 34315495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipoprotein(a) levels (Q1 to Q4)
Number of subjects: 9248
Study 32756916 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity troponin (hsTn) testing
Number of subjects: 8635
Study 35085742 — intervention group
Group type: EXPERIMENTAL
Intervention: Shugan granules
Number of subjects: 400
Study 35085742 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 400
Study 33971861 — intervention group
Group type: EXPERIMENTAL
Intervention: dr. Bart app
Number of subjects: 214
Study 37461117 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal group (virtual care at home including exercise, nutrition counselling, medication consultation)
Number of subjects: 70
Study 37461117 — intervention group
Group type: COMPARATOR
Intervention: Socialization group (once-weekly phone calls)
Number of subjects: 70
Study 32998148 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingerroot (Boesenbergia rotunda) extract (350 mg extract powder, 3 times daily for 4 weeks)
Number of subjects: 160
Study 32998148 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingerroot (Boesenbergia rotunda) extract
Number of subjects: 160
Study 32998148 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 32067908 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial plaque excision and grafting using Tachosil®
Number of subjects: 21
Study 35761751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (group education and telephone coaching)
Number of subjects: 30
Study 35761751 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 30
Study 34799582 — intervention group
Group type: EXPERIMENTAL
Intervention: CUTseq for high-throughput low-input SCNA profiling
Number of subjects: 0
Study 34799582 — intervention group
Group type: EXPERIMENTAL
Intervention: mfIHC for quantitative immuno-profiling
Number of subjects: 0
Study 34799582 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis of SCNA and immune profiling
Number of subjects: 0
Study 33333491 — intervention group
Group type: EXPERIMENTAL
Intervention: Osteopathic Manipulative Treatment (OMT)
Number of subjects: 82
Study 33333491 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Program (EP)
Number of subjects: 82
Study 33333491 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 32352903 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane (SAP) block with 20 mL of 0.2% ropivacaine and 1 μg/mL fentanyl as bolus followed by infusion at 8 mL/h
Number of subjects: 50
Study 32352903 — intervention group
Group type: EXPERIMENTAL
Intervention: Serratus anterior plane (SAP) block
Number of subjects: 50
Study 32352903 — intervention group
Group type: COMPARATOR
Intervention: Control group received saline for both bolus and infusion
Number of subjects: 50
Study 36185291 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated yoga therapy intervention during chemotherapy
Number of subjects: 0
Study 36185291 — intervention group
Group type: COMPARATOR
Intervention: Standard care during chemotherapy
Number of subjects: 0
Study 33827835 — intervention group
Group type: EXPERIMENTAL
Intervention: Perioperative virtual reality‐based stress reduction exercises twice daily
Number of subjects: 54
Study 33827835 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to classical music twice daily
Number of subjects: 54
Study 33827835 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 54
Study 34956580 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous subcutaneous infusion of quick‐acting insulin analogues
Number of subjects: 92
Study 34898333 — intervention group
Group type: EXPERIMENTAL
Intervention: South Sudan Mental Health Assessment Scale (24-item measure)
Number of subjects: 3137
Study 34898333 — intervention group
Group type: EXPERIMENTAL
Intervention: Test-retest reliability assessment
Number of subjects: 3137
Study 34898333 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent validity assessment
Number of subjects: 3137
Study 32826102 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer education intervention (two one-hour training sessions on the third day after myocardial infarction)
Number of subjects: 70
Study 32826102 — intervention group
Group type: COMPARATOR
Intervention: Routine care (control group)
Number of subjects: 70
Study 36441371 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol beverages
Number of subjects: 30
Study 36441371 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36441371 — intervention group
Group type: EXPERIMENTAL
Intervention: Neutral movie clips
Number of subjects: 30
Study 36441371 — intervention group
Group type: EXPERIMENTAL
Intervention: Erotic movie clips
Number of subjects: 30
Study 33789403 — intervention group
Group type: EXPERIMENTAL
Intervention: Systematized weaning of opioids for infants with NOWS
Number of subjects: 0
Study 33789403 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 32337796 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored fall prevention education program
Number of subjects: 30
Study 32337796 — intervention group
Group type: EXPERIMENTAL
Intervention: Access to therapy or social supports
Number of subjects: 30
Study 32337796 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of physical and social support
Number of subjects: 30
Study 33751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Balanced occlusal scheme
Number of subjects: 60
Study 33751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Lingualized occlusal scheme
Number of subjects: 60
Study 33751001 — intervention group
Group type: EXPERIMENTAL
Intervention: Monoplane occlusal scheme
Number of subjects: 60
Study 33472507 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine (SA)
Number of subjects: 120
Study 33472507 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthokeratology (OK)
Number of subjects: 120
Study 34669096 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter A (note on family history of breast/ovarian cancer), n=3,402
Number of subjects: 6802
Study 34669096 — intervention group
Group type: COMPARATOR
Intervention: Letter B (note with details on possible implications of family history patterns), n=3,200
Number of subjects: 6802
Study 34669096 — intervention group
Group type: EXPERIMENTAL
Intervention: Letter B (note with details on possible implications of family history patterns)
Number of subjects: 6802
Study 34669096 — intervention group
Group type: COMPARATOR
Intervention: Letter A (note on family history of breast/ovarian cancer)
Number of subjects: 6802
Study 34669096 — intervention group
Group type: EXPERIMENTAL
Intervention: In-person consultation offered to women traced by the Genetic Unit (G.U.)
Number of subjects: 6802
Study 34669096 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing performed for women who attended the consultation
Number of subjects: 6802
Study 33772885 — intervention group
Group type: EXPERIMENTAL
Intervention: Extruded feed (EF)
Number of subjects: 0
Study 33772885 — intervention group
Group type: COMPARATOR
Intervention: Pelleted feed (PF)
Number of subjects: 0
Study 34554369 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial warning labels
Number of subjects: 229
Study 34554369 — intervention group
Group type: COMPARATOR
Intervention: Text-only cigarette warning
Number of subjects: 229
Study 32785785 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-lumen irrigation-suction tube
Number of subjects: 761
Study 32785785 — intervention group
Group type: COMPARATOR
Intervention: Passive drainage tube
Number of subjects: 761
Study 36048232 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR) set during flexible cystoscopy
Number of subjects: 270
Study 36048232 — intervention group
Group type: COMPARATOR
Intervention: Control group (no VR set)
Number of subjects: 270
Study 33555030 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab, bortezomib and dexamethasone (D‐Vd)
Number of subjects: 0
Study 33555030 — intervention group
Group type: EXPERIMENTAL
Intervention: Daratumumab monotherapy (after Cycle 8)
Number of subjects: 0
Study 33555030 — intervention group
Group type: COMPARATOR
Intervention: Bortezomib and dexamethasone (Vd)
Number of subjects: 0
Study 34315242 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 91
Study 34315242 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal Massage
Number of subjects: 91
Study 34315242 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 91
Study 34470598 — intervention group
Group type: EXPERIMENTAL
Intervention: BOOST pACP program (three conversation sessions)
Number of subjects: 0
Study 34470598 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 0
Study 34595983 — intervention group
Group type: EXPERIMENTAL
Intervention: Inebilizumab
Number of subjects: 75
Study 34263930 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic platelet transfusions
Number of subjects: 0
Study 33290939 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive‐Behavioral Social Skills Training and Compensatory Cognitive Training (CBSST‐CCT)
Number of subjects: 55
Study 33290939 — intervention group
Group type: COMPARATOR
Intervention: Goal‐Focused Supportive Contact (SC)
Number of subjects: 55
Study 33008106 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic Pilates Training (HPTG)
Number of subjects: 32
Study 33008106 — intervention group
Group type: EXPERIMENTAL
Intervention: Normoxic Pilates Training (NPTG)
Number of subjects: 32
Study 33008106 — intervention group
Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 32
Study 34915741 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-101 (6 once-weekly instillations via retrograde catheter)
Number of subjects: 71
Study 34915741 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-101 (maintenance instillations)
Number of subjects: 71
Study 34915741 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-101 (no maintenance instillations)
Number of subjects: 71
Study 34915741 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-101 (≥1 maintenance instillation)
Number of subjects: 71
Study 34915741 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-101
Number of subjects: 71
Study 33397290 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium supplementation
Number of subjects: 0
Study 33397290 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 0
Study 32732703 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical and technology-based innovations for HSV keratitis management
Number of subjects: 0
Study 32732703 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation of evidence-based medicine
Number of subjects: 0
Study 32732703 — intervention group
Group type: EXPERIMENTAL
Intervention: Population-wide disease registries
Number of subjects: 0
Study 36244331 — intervention group
Group type: COMPARATOR
Intervention: Tamsulosin 0.4 mg once daily
Number of subjects: 102
Study 36244331 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron 50 mg + Tamsulosin 0.4 mg once daily
Number of subjects: 102
Study 33814529 — intervention group
Group type: EXPERIMENTAL
Intervention: Change greater than or equal to the median %ΔEPA/AA ratio (Group 2)
Number of subjects: 965